Human antithrombin III concentrate (CSL Behring)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman antithrombin III concentrate (CSL Behring)
Drug Alias Name人抗凝血酶IIIThrombotrol-VF
ClassificationBiologics > Protein drugs > Enzyme > Non-recombinant enzyme
Mechanisms of ActionAntithrombin-III inhibitors
TargetsAntithrombin-III
Therapy Area/IndicationsThrombosisPulmonary Embolism
Global Approved IndicationsThrombosisPulmonary Embolism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAustralia
Original Approved Date2005/04/01
Country/TerritoryNew ZealandAustraliaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring Llc
Inactive CompaniesN/A
Active IndicationsThrombosisPulmonary Embolism
Inactive IndicationsN/A

Other Information

ATC CodeB01AB02
Related LinksN/A